安科生物
(300009)
| 流通市值：98.96亿 | | | 总市值：134.32亿 |
| 流通股本：12.31亿 | | | 总股本：16.71亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 179,910,851.96 | 281,509,964.36 | 174,504,955.49 | 250,202,239.26 |
| 交易性金融资产 | 1,144,171,738.04 | 1,108,193,434.55 | 1,418,343,860.56 | 1,191,953,897.57 |
| 应收票据及应收账款 | 376,299,820.6 | 402,054,667 | 433,106,965.01 | 407,943,261.88 |
| 其中：应收票据 | - | 202,920 | - | - |
| 应收账款 | 376,299,820.6 | 401,851,747 | 433,106,965.01 | 407,943,261.88 |
| 应收款项融资 | 46,914,770.74 | 38,979,488.13 | 62,695,903.98 | 87,620,594.08 |
| 预付款项 | 25,366,613.41 | 11,323,689.57 | 14,969,513.92 | 10,534,603.06 |
| 其他应收款合计 | 134,735,374.82 | 54,235,562.34 | 49,958,651.1 | 35,163,419.29 |
| 存货 | 311,253,058.49 | 284,747,825.42 | 274,215,582.35 | 252,754,226.91 |
| 一年内到期的非流动资产 | 105,985,999.99 | 42,322,666.68 | 64,862,333.34 | 141,072,638.9 |
| 其他流动资产 | 16,646,022.42 | 18,376,274.03 | 16,902,394.6 | 17,829,463.16 |
| 流动资产合计 | 2,341,284,250.47 | 2,241,743,572.08 | 2,509,560,160.35 | 2,395,074,344.11 |
| 非流动资产: | | | | |
| 债权投资 | - | 63,009,111.1 | 104,684,666.67 | 104,044,666.67 |
| 长期股权投资 | 157,297,660.15 | 161,307,516.96 | 146,115,840.98 | 150,955,638.5 |
| 其他权益工具投资 | 94,548,962.44 | 120,039,616.66 | 409,190,487.84 | 380,719,660.31 |
| 其他非流动金融资产 | 153,564,474.12 | 153,564,474.12 | 153,564,474.12 | 153,564,474.12 |
| 投资性房地产 | 6,410,361.74 | 6,564,983 | 6,807,006.39 | 7,864,401.5 |
| 固定资产 | 1,033,885,073.18 | 1,054,972,194.51 | 983,721,854.53 | 972,048,369.33 |
| 在建工程 | 522,176,915.74 | 529,794,450.46 | 588,696,348.53 | 620,769,552.32 |
| 使用权资产 | 25,367,435.42 | 27,259,030.11 | 29,967,837.53 | 31,808,733.22 |
| 无形资产 | 379,470,940.94 | 378,378,354.44 | 385,720,770.62 | 393,662,228.44 |
| 开发支出 | 218,432,390.05 | 209,316,856.06 | 202,042,898.29 | 198,869,491.79 |
| 商誉 | 66,556,732.24 | 66,556,732.24 | 66,556,732.24 | 66,556,732.24 |
| 长期待摊费用 | 7,179,971.35 | 7,683,351.73 | 6,864,531.54 | 5,926,124.77 |
| 递延所得税资产 | 88,027,969.11 | 85,150,106.45 | 60,136,276.28 | 61,504,791.56 |
| 其他非流动资产 | 54,029,619.93 | 20,816,390.56 | 10,975,147.96 | 4,284,199.92 |
| 非流动资产合计 | 2,806,948,506.41 | 2,884,413,168.4 | 3,155,044,873.52 | 3,152,579,064.69 |
| 资产总计 | 5,148,232,756.88 | 5,126,156,740.48 | 5,664,605,033.87 | 5,547,653,408.8 |
| 流动负债: | | | | |
| 短期借款 | 50,029,305.57 | 71,004,843.66 | - | - |
| 应付票据及应付账款 | 184,845,867.52 | 184,716,967.49 | 207,501,992.25 | 252,277,019.05 |
| 其中：应付票据 | 19,021,014 | 17,820,000 | 27,190,000 | 31,420,000 |
| 应付账款 | 165,824,853.52 | 166,896,967.49 | 180,311,992.25 | 220,857,019.05 |
| 合同负债 | 17,980,666.53 | 12,633,202.34 | 13,250,177.49 | 8,085,093.79 |
| 应付职工薪酬 | 73,705,086.57 | 63,565,273.5 | 110,395,754.17 | 103,957,602.58 |
| 应交税费 | 62,220,815.71 | 48,447,194.98 | 77,252,216.8 | 73,426,264.27 |
| 其他应付款合计 | 158,051,706.41 | 168,463,580.88 | 166,431,762.74 | 193,688,630.33 |
| 应付股利 | 339,312.5 | 339,312.5 | 771,552 | 10,627,347 |
| 一年内到期的非流动负债 | 7,750,179.6 | 7,104,150.22 | 7,821,784.36 | 7,664,748.21 |
| 其他流动负债 | 1,210,885.21 | 864,259.55 | 891,332.59 | 600,859.83 |
| 流动负债合计 | 555,794,513.12 | 556,799,472.62 | 583,545,020.4 | 639,700,218.06 |
| 非流动负债: | | | | |
| 租赁负债 | 17,834,325.95 | 20,493,853.82 | 22,418,040.81 | 25,291,823.91 |
| 预计负债 | 2,311,638.93 | 2,473,670.83 | 2,311,638.93 | 2,311,638.93 |
| 递延收益 | 126,185,700.78 | 127,437,124.63 | 125,265,553.73 | 123,427,938.2 |
| 递延所得税负债 | 7,074,246.96 | 7,245,729.9 | 26,529,709.09 | 20,565,152.74 |
| 非流动负债合计 | 153,405,912.62 | 157,650,379.18 | 176,524,942.56 | 171,596,553.78 |
| 负债合计 | 709,200,425.74 | 714,449,851.8 | 760,069,962.96 | 811,296,771.84 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,670,700,708 | 1,670,700,708 | 1,671,320,708 | 1,672,521,258 |
| 资本公积 | 461,374,829.8 | 455,123,350.02 | 449,393,714.26 | 459,497,791.32 |
| 减:库存股 | 2,135,415 | 2,135,415 | 8,321,280 | 14,554,154.5 |
| 其他综合收益 | -177,567,026.32 | -155,498,733.23 | 87,027,001.01 | 64,761,046.22 |
| 盈余公积 | 503,427,398.18 | 503,427,398.18 | 503,427,398.18 | 503,427,398.18 |
| 未分配利润 | 1,924,093,021.18 | 1,788,022,763.65 | 2,040,600,758.97 | 1,872,361,712.07 |
| 归属于母公司股东权益合计 | 4,379,893,515.84 | 4,259,640,071.62 | 4,743,448,300.42 | 4,558,015,051.29 |
| 少数股东权益 | 59,138,815.3 | 152,066,817.06 | 161,086,770.49 | 178,341,585.67 |
| 股东权益合计 | 4,439,032,331.14 | 4,411,706,888.68 | 4,904,535,070.91 | 4,736,356,636.96 |
| 负债和股东权益合计 | 5,148,232,756.88 | 5,126,156,740.48 | 5,664,605,033.87 | 5,547,653,408.8 |
| 公告日期 | 2026-10-24 | 2026-08-26 | 2026-04-24 | 2026-03-31 |
| 审计意见(境内) | | | | 标准无保留意见 |